We answer three critical questions rapidly: Where is it? How aggressive is it? What is its molecular fingerprint? Our integrated pathway delivers all answers within days:
Contrast-enhanced MRI reveals location, size, edema, and mass effect. Advanced sequences (DWI, PWI, MRS) assess cellularity and blood flow.
For deep or eloquent-area tumors where resection carries high risk, frameless navigation obtains tissue diagnosis with millimeter accuracy.
NGS and methylation profiling analyze IDH1/2 mutation, MGMT promoter methylation, 1p/19q codeletion, TERT promoter, EGFR amplification, and histone mutations. Directly determines prognosis and targeted therapy eligibility.
Maps language, motor, and visual cortices and white matter tracts—preserving function during surgery.